Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621268 · ClinicalTrials.gov registry record · Phase 1
Minimally Invasive Imagery With Indocyanine Green
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT02621268: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT02621268 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621268, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
Determine if ICG administered pre-operatively, then imaged intraoperatively using our cameras, will aid in the identification of a suspected thoracic nodules, margins, lymph nodes and satellite nodules during minimally invasive procedures. The investigators intend on enrolling 48 Subjects in this study. The study is focusing on patients presenting with suspected thoracic cancers who are considered to be good minimally invasive surgical candidates
Interventions
- DRUG Indocyanine Green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02621268
The ClinicalTrials.gov registry entry for NCT02621268 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green is the first listed.
NCT02621268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02621268 about?
NCT02621268 is a clinical study titled "Minimally Invasive Imagery With Indocyanine Green". Determine if ICG administered pre-operatively, then imaged intraoperatively using our cameras, will aid in the identification of a suspected thoracic nodules, margins, lymph nodes and satellite nodules during minimally invasive procedures. The investigators intend on enrolling 48 Subjects in this st...
What is the current status of trial NCT02621268?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2014-11. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02621268?
The interventions under investigation include: Indocyanine Green (DRUG).
Who is sponsoring clinical trial NCT02621268?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.